Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Immunoprecise Antibodies Ltd

(TSX-V: IPA.VN)
Add to Portfolio
-0.010 (-1.67%)
as of Feb 19, 2020

Last 0.590
Change -0.010 (-1.67%)
Open 0.590
Prev. Close 0.600
Today's Range
0.570
0.600
52wk Range
0.445
0.850
Volume 45,100
Avg Volume 48,083

Perfomance Comparison

Name Today 3-Month 1-Year
IPA.VN -1.67% -1.67% -7.81%
$TXCX +0.38% +6.35% +12.47%
$TXCI +0.38% +6.31% +12.41%
DJIA +0.40% +6.03% +13.35%
S&P 500 +0.47% +8.62% +21.81%

Key Statistics

Annual EPS -0.130
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K 40,797
Weighted Alpha -19.60
Standard Deviation -0.45
Profit Margin -0.75%
Beta 0.779

Growth Rates

YTD +3.51%
1-Year -21.05%
3-Year -58.62%

Opinion

Sell Hold Buy

Recent Headlines

ImmunoPrecise integrates SGI-DNA's benchtop automated

CNW Group via COMTEX - Mon Jan 20, 08:00AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, and SGI-DNA, INC., a company dedicated to d(full story)
IPATF: 0.4357 (+0.0079), IPA.VN: 0.590 (-0.010)

ImmunoPrecise Subsidiary Joins Genmab and Merus in

CNW Group via COMTEX - Thu Jan 09, 08:59AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced that its wholly owned subsi(full story)
IPATF: 0.4357 (+0.0079), IPA.VN: 0.590 (-0.010), GMAB: 24.26 (+0.19), MRUS: 19.44 (+0.29)

ImmunoPrecise Antibodies Will Be in San Francisco

CNW Group via COMTEX - Mon Jan 06, 09:30AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) announced today IPA will be in San Francisco during the J.P. Morgan 38th Annual Healthcare Conference events running from January 13-16, 2020(full story)
JPM: 137.49 (+1.85), IPA.VN: 0.590 (-0.010), IPATF: 0.4357 (+0.0079)

ImmunoPrecise Announces Record Quarterly Revenue and

CNW Group via COMTEX - Tue Dec 17, 09:08AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) announces today that it has released its financial results for the second quarter ended October 31, 2019. The financial statements and relate(full story)
IPA.VN: 0.590 (-0.010), IPATF: 0.4357 (+0.0079)

ImmunoPrecise Announces Annual General Meeting Results

CNW Group via COMTEX - Mon Dec 02, 08:00AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) announces that all resolutions were passed by the shareholders at its annual general meeting ("AGM") held in Vancouver, British Columbia, on(full story)
IPATF: 0.4357 (+0.0079), IPA.VN: 0.590 (-0.010)